RecruitingNCT07359690

Multimodal Analysis of Endomyocardial Biopsies


Sponsor

University Hospital, Essen

Enrollment

216 participants

Start Date

Oct 27, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to pursue a multimodal approach to identify the molecular signatures and immune signalling molecules of various myocardial diseases and thereby contribute to improving diagnosis and therapy. The main aim is: -Identification of molecular profiles (e.g., proteome, lipidome, metabolome) and immune signalling profiles that are specifically associated with different myocardial diseases and the post-heart transplantation course. Participants already receiving an endomyocardial biopsy as part of their regular medical care will be enrolled. An additional biopsy sample will be taken for the above mentioned research.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Patients aged \>18 years with a clinical indication for endomyocardial biopsy.
  • Patients capable of providing informed consent who have signed the consent form for participation in the study.

Exclusion Criteria4

  • Patients without a clinical indication for endomyocardial biopsy (EMB).
  • Pregnant individuals.
  • Patients incapable of providing informed consent.
  • Women of childbearing potential who are not using adequate contraception.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, Germany

Essen, North Rhine-Westphalia, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07359690


Related Trials